Ardelyx Stock (NASDAQ:ARDX), Quotes and News Summary

Q: What sector and industry does Ardelyx (ARDX) operate in?

Ardelyx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Ardelyx Stock (NASDAQ: ARDX) stock price, news, charts, stock research, profile.

Open	$6.450
Close	-
Volume / Avg.	1.677M / 5.525M
Day Range	6.410 - 6.735
52 Wk Range	3.160 - 10.130
Market Cap	$1.519B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	37
Short Interest	17.04%
Days to Cover	6.86

Recent News

Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of Byrna Technologies Inc. (NASDAQ: BYRN) rose sharply during Friday’s session after the company reported better-than-expected first-quarter revenue, and announced a CFO transition.

Avi Kapoor

What's Going On With Ardelyx Stock After Earnings?

Ardelyx reported ending 2023 with $184.3 million in cash and investments and expects full-year 2024 U.S. net product sales revenue for Ibsrela to be between $140 million and $150 million. Wedbush analyst Laura Chico reiterated Ardelyx with an Outperform rating and maintained a $13 price target following the print.

Erica Kollmann

Why AXT Shares Are Trading Higher By Around 36%; Here Are 20 Stocks Moving Premarket

Shares of AXT, Inc. (NASDAQ: AXTI) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Dec 23

Jan

Feb

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Ardelyx (ARDX) stock?

You can purchase shares of Ardelyx (NASDAQ: ARDX) through any online brokerage.

View our list of the best stock brokerages.

Who are Ardelyx's (ARDX) competitors?

Other companies in Ardelyx’s space includes: Twist Bioscience (NASDAQ:TWST), Gyre Therapeutics (NASDAQ:GYRE), Syndax Pharmaceuticals (NASDAQ:SNDX), Fusion Pharmaceuticals (NASDAQ:FUSN) and Day One Biopharmaceutical (NASDAQ:DAWN).

What is the target price for Ardelyx (ARDX) stock?

The latest price target for Ardelyx (NASDAQ: ARDX) was reported by Wedbush on Wednesday, April 17, 2024. The analyst firm set a price target for 14.00 expecting ARDX to rise to within 12 months (a possible 113.74% upside). 15 analyst firms have reported ratings in the last year.

Current Stock Price for Ardelyx (ARDX)?

The stock price for Ardelyx (NASDAQ: ARDX) is $6.55 last updated Today at May 1, 2024 at 12:40 PM EDT.

Does Ardelyx (ARDX) pay a dividend?

There are no upcoming dividends for Ardelyx.

When is Ardelyx (NASDAQ:ARDX) reporting earnings?

Ardelyx’s Q2 earnings are confirmed for Wednesday, July 31, 2024.

Is Ardelyx (ARDX) going to split?

There is no upcoming split for Ardelyx.

What sector and industry does Ardelyx (ARDX) operate in?

Ardelyx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-